Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 6/20 | 0.58 |
| ▸ | ENPEP | Q07075 | 6/20 | 0.52 |
| ▸ | GSTK1 | Q9Y2Q3 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.43 |
| ▸ | ANPEP | P15144 | 3/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3517117 | 0.93 | FOLH1 (0.62) | FOLH1ENPEPGSTK1LMNASLC22A6 | |
| SCHEMBL3521467 | 0.91 | FOLH1 (0.60) | FOLH1ENPEPGSTK1LMNASLC22A6 | |
| SCHEMBL18422675 | 0.91 | FOLH1 (0.60) | FOLH1ENPEPGSTK1LMNATSHR | |
| SCHEMBL3521389 | 0.91 | FOLH1 (0.52) | FOLH1ENPEPGSTK1LMNASLC22A6 | |
| SCHEMBL3517277 | 0.91 | FOLH1 (0.61) | FOLH1ENPEPGSTK1ANPEP | |
| SCHEMBL11797545 | 0.86 | FOLH1 (0.52) | FOLH1ENPEPGSTK1LMNASLC22A6 | |
| SCHEMBL3515557 | 0.84 | FOLH1 (0.62) | FOLH1ENPEPGSTK1ANPEP | |
| Dihydrolipoic Acid SCHEMBL1115003 | 0.84 | FOLH1 (0.56) | FOLH1ENPEPGSTK1LMNASLC22A6 | |
| Dihydrolipoic Acid SCHEMBL867951 | 0.84 | FOLH1 (0.56) | FOLH1ENPEPGSTK1LMNASLC22A6 | |
| Dihydrolipoic Acid SCHEMBL618576 | 0.84 | FOLH1 (0.56) | FOLH1ENPEPGSTK1LMNASLC22A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100190902-A1 | ALKYLTIN SULFANYL ESTER THIOLS | CHEMTURA CORPORATION (US) | 2010-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100190902-A1 | ALKYLTIN SULFANYL ESTER THIOLS | SULT1E1, SULT1A1, TST | FOLH1 4882/4885ENPEP 3338/4885GSTK1 351/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.